LISDEXAMFETAMINE 30 MG CAPSULE

Lisdexamfetamine dimesylate
$3.0486per EA
DEA Schedule CII

Strength

30 mg/1

Manufacturer

Sandoz Inc.

NDC

00781247701

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

LISDEXAMFETAMINE DIMESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA202836

On Market Since

9/16/2025

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price History

1W

0.0%

1M

+3.0%

3M

-4.2%

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-11.3%